These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32059344)

  • 1. Molecular Approach to Cutaneous Squamous Cell Carcinoma: From Pathways to Therapy.
    Palazzo E; Morasso MI; Pincelli C
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma.
    Li F; Liao J; Duan X; He Y; Liao Y
    J Cell Biochem; 2018 Dec; 119(12):10393-10405. PubMed ID: 30145798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression and Implications of Melanoma-associated Antigen A12 in Pathogenesis of Human Cutaneous Squamous Cell Carcinoma.
    Zhao G; Bae JY; Zheng Z; Park HS; Chung KY; Roh MR; Jin Z
    Anticancer Res; 2019 Apr; 39(4):1849-1857. PubMed ID: 30952725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma.
    Watt SA; Pourreyron C; Purdie K; Hogan C; Cole CL; Foster N; Pratt N; Bourdon JC; Appleyard V; Murray K; Thompson AM; Mao X; Mein C; Bruckner-Tuderman L; Evans A; McGrath JA; Proby CM; Foerster J; Leigh IM; South AP
    Oncogene; 2011 Nov; 30(46):4666-77. PubMed ID: 21602893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous Squamous Cell Carcinoma: From Biology to Therapy.
    Corchado-Cobos R; García-Sancha N; González-Sarmiento R; Pérez-Losada J; Cañueto J
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies.
    Al-Rohil RN; Tarasen AJ; Carlson JA; Wang K; Johnson A; Yelensky R; Lipson D; Elvin JA; Vergilio JA; Ali SM; Suh J; Miller VA; Stephens PJ; Ganesan P; Janku F; Karp DD; Subbiah V; Mihm MC; Ross JS
    Cancer; 2016 Jan; 122(2):249-57. PubMed ID: 26479420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.
    Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ
    Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma.
    García-Sancha N; Corchado-Cobos R; Pérez-Losada J; Cañueto J
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-Binding Protein IGF2BP1 in Cutaneous Squamous Cell Carcinoma.
    Kim T; Havighurst T; Kim K; Hebbring SJ; Ye Z; Aylward J; Keles S; Xu YG; Spiegelman VS
    J Invest Dermatol; 2017 Mar; 137(3):772-775. PubMed ID: 27856289
    [No Abstract]   [Full Text] [Related]  

  • 10. MiR-1193 was sponged by LINC00963 and inhibited cutaneous squamous cell carcinoma progression by targeting SOX4.
    Wang J; Li C; Xu L; Yang C; Zhang X
    Pathol Res Pract; 2019 Oct; 215(10):152600. PubMed ID: 31477326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the interplay between senescent dermal fibroblasts and cutaneous squamous cell carcinoma cell lines at different stages of tumorigenesis.
    Toutfaire M; Dumortier E; Fattaccioli A; Van Steenbrugge M; Proby CM; Debacq-Chainiaux F
    Int J Biochem Cell Biol; 2018 May; 98():113-126. PubMed ID: 29550586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of miRNAs in cutaneous squamous cell carcinoma.
    Yu X; Li Z
    J Cell Mol Med; 2016 Jan; 20(1):3-9. PubMed ID: 26508273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microRNA landscape of cutaneous squamous cell carcinoma.
    Konicke K; López-Luna A; Muñoz-Carrillo JL; Servín-González LS; Flores-de la Torre A; Olasz E; Lazarova Z
    Drug Discov Today; 2018 Apr; 23(4):864-870. PubMed ID: 29317340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent Fusion Gene ADCK4-NUMBL in Cutaneous Squamous Cell Carcinoma Mediates Cell Proliferation.
    Egashira S; Jinnin M; Makino K; Ajino M; Shimozono N; Okamoto S; Tazaki Y; Hirano A; Ide M; Kajihara I; Aoi J; Harada M; Igata T; Masuguchi S; Fukushima S; Ihn H
    J Invest Dermatol; 2019 Apr; 139(4):954-957. PubMed ID: 30395845
    [No Abstract]   [Full Text] [Related]  

  • 15. p53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling.
    Piipponen M; Nissinen L; Riihilä P; Farshchian M; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
    Am J Pathol; 2020 Feb; 190(2):503-517. PubMed ID: 31837949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAGEA3 Expression in Cutaneous Squamous Cell Carcinoma Is Associated with Advanced Tumor Stage and Poor Prognosis.
    Abikhair M; Roudiani N; Mitsui H; Krueger JG; Pavlick A; Lee J; Therrien JP; Meehan SA; Felsen D; Carucci JA
    J Invest Dermatol; 2017 Mar; 137(3):775-778. PubMed ID: 27826009
    [No Abstract]   [Full Text] [Related]  

  • 17. miR-497 promotes the progression of cutaneous squamous cell carcinoma through FAM114A2.
    Wei XH; Gu XL; Zhou XT; Ma M; Lou CX
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7348-7355. PubMed ID: 30468480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetics of cutaneous squamous cell carcinogenesis.
    Campos MA; Lopes JM; Soares P
    Eur J Dermatol; 2018 Oct; 28(5):597-605. PubMed ID: 30530431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and new perspectives in the treatment of advanced cutaneous squamous cell carcinoma.
    Brancaccio G; Moscarella E; Briatico G; Verolino P; Alfano R; Argenziano G
    Minerva Med; 2020 Dec; 111(6):589-600. PubMed ID: 32955822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
    O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
    J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.